HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/2/G401    most recent 00454.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Kolachala, V. L. Articles by Sitaraman, S. V. Search for Related Content PubMed PubMed Citation Articles by Kolachala, V. L. Articles by Sitaraman, S. V.

INVITED REVIEWS

Purinergic receptors in gastrointestinal inflammation

Division of Digestive Diseases, Emory University School of Medicine, Atlanta, Georgia

Submitted 3 October 2007 ; accepted in final form 2 December 2007

Purinergic receptors comprise a family of transmembrane receptors that are activated by extracellular nucleosides and nucleotides. The two major classes of purinergic receptors, P1 and P2, are expressed widely in the gastrointestinal tract as well as immune cells. The purinergic receptors serve a variety of functions from acting as neurotransmitters, to autocoid and paracrine signaling, to cell activation and immune response. Nucleosides and nucleotide agonist of purinergic receptors are released by many cell types in response to specific physiological signals, and their levels are increased during inflammation. In the past decade, the advent of genetic knockout mice and the development of highly potent and selective agonists and antagonists for the purinergic receptors have significantly advanced the understanding of purinergic receptor signaling in health and inflammation. In fact, agonist/antagonists of purinergic receptors are emerging as therapeutic modalities to treat intestinal inflammation. In this article, the distribution of the purinergic receptors in the gastrointestinal tract and their physiological and pathophysiological role in intestinal inflammation will be reviewed.

adenosine receptor; P2 receptor; inflammation

This article has been cited by other articles:

				R. Corriden and P. A. Insel Basal Release of ATP: An Autocrine-Paracrine Mechanism for Cell Regulation Sci. Signal., January 12, 2010; 3(104): re1 - re1. [Abstract] [Full Text] [PDF]

				C. Luna, G. Li, J. Qiu, P. Challa, D. L. Epstein, and P. Gonzalez Extracellular Release of ATP Mediated by Cyclic Mechanical Stress Leads to Mobilization of AA in Trabecular Meshwork Cells Invest. Ophthalmol. Vis. Sci., December 1, 2009; 50(12): 5805 - 5810. [Abstract] [Full Text] [PDF]

				S. Neshat, M. deVries, A. R. Barajas-Espinosa, L. Skeith, S. P. Chisholm, and A. E. Lomax Loss of purinergic vascular regulation in the colon during colitis is associated with upregulation of CD39 Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G399 - G405. [Abstract] [Full Text] [PDF]

				G. Burnstock Purinergic receptors as future targets for treatment of functional GI disorders Gut, September 1, 2008; 57(9): 1193 - 1194. [Full Text] [PDF]